Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
NYSE:CRL
Price:
345
USD
0.04%
Market Closed
Market Cap:
$16.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Charles River Laboratories International Inc
NYSE:CRL
|
US |
|
S
|
Sartorius AG
XHAN:SRT
|
DE |
Wall St Price Targets
CRL Price Forecast
Based on 19 analysts
Based on 19 analysts
-5% Downside
from
$345
today
Charles River Laboratories International Inc (CRL)’s 12-month stock price forecast through October 2027 has a consensus target of $327.42, implying 5% downside. The forecast is based on price targets from 19 Wall Street analysts.
CRL Analyst Rating
Based on 18 analysts
Based on 18 analysts
Analysts rate CRL Buy, with 15 of 18 recommending Buy or Strong buy.
Charles River Laboratories International Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRL's stock price target?
Price Target
327.42
USD
327.42
USD
According to Wall Street analysts, the average 1-year price target for CRL is 327.42 USD with a low forecast of 147.27 USD and a high forecast of 374.85 USD.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
15%
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 15%.